These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8887017)

  • 1. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus.
    Okuda Y; Mizutani M; Ogawa M; Sone H; Asano M; Asakura Y; Isaka M; Suzuki S; Kawakami Y; Field JB; Yamashita K
    J Diabetes Complications; 1996; 10(5):280-7. PubMed ID: 8887017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients.
    Shimizu H; Ohtani K; Tanaka Y; Sato N; Mori M; Shimomura Y
    Diabetes Res Clin Pract; 1995 Apr; 28(1):35-40. PubMed ID: 7587910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
    Elajami TK; Alfaddagh A; Lakshminarayan D; Soliman M; Chandnani M; Welty FK
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus.
    Mori Y; Murakawa Y; Katoh S; Hata S; Yokoyama J; Tajima N; Ikeda Y; Nobukata H; Ishikawa T; Shibutani Y
    Metabolism; 1997 Dec; 46(12):1458-64. PubMed ID: 9439543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.
    Uchida K; Kigoshi T; Nakano S; Ishii T; Kitazawa M; Morimoto S
    Clin Ther; 1995; 17(3):460-6. PubMed ID: 7585850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.
    Nakamura N; Hamazaki T; Kobayashi M; Ohta M; Okuda K
    In Vivo; 1998; 12(3):311-4. PubMed ID: 9706476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echography.
    Okuda Y; Mizutani M; Ogawa M; Sone H; Asano M; Tsurushima Y; Morishima Y; Asakura Y; Suzuki S; Isaka M
    Diabetes Res; 1993; 22(2):87-95. PubMed ID: 8205741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia.
    Minami A; Ishimura N; Sakamoto S; Takishita E; Mawatari K; Okada K; Nakaya Y
    Br J Nutr; 2002 Feb; 87(2):157-62. PubMed ID: 11895168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of n-3 fatty acid administration on selected indicators of cardiovascular disease risk in patients with type 2 diabetes mellitus].
    Habán P; Simoncic R; Klvanová I; Ozdín L; Zideková E
    Bratisl Lek Listy; 1998 Jan; 99(1):37-42. PubMed ID: 9588078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy.
    Okuda Y; Mizutani M; Ikegami T; Ueno E; Yamashita K
    Arzneimittelforschung; 1992 Apr; 42(4):540-2. PubMed ID: 1642679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
    Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
    Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y
    Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomised clinical trial.
    Sarbolouki S; Javanbakht MH; Derakhshanian H; Hosseinzadeh P; Zareei M; Hashemi SB; Dorosty AR; Eshraghian MR; Djalali M
    Singapore Med J; 2013 Jul; 54(7):387-90. PubMed ID: 23900468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables.
    Maki KC; Bobotas G; Dicklin MR; Huebner M; Keane WF
    J Clin Lipidol; 2017; 11(1):102-109. PubMed ID: 28391875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic acid stimulates nitric oxide production and decreases cardiac noradrenaline in diabetic rats.
    Nishimura M; Nanbu A; Komori T; Ohtsuka K; Takahashi H; Yoshimura M
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):618-24. PubMed ID: 10901392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor study.
    Virtanen JK; Mursu J; Voutilainen S; Uusitupa M; Tuomainen TP
    Diabetes Care; 2014; 37(1):189-96. PubMed ID: 24026545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
    Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.